Skip to content

Evaluation of Post Operative Pain in Retreatment of Molars Using Different Irrigant

Assessment of Post Operative Pain Following Root Canal Retreatment in Molars Using Four Different Combination of Irrigants : A Prospective Clinical Study

Status
UNKNOWN
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04250519
Enrollment
150
Registered
2020-01-31
Start date
2020-02-03
Completion date
2021-04-15
Last updated
2020-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Root Canal Infection

Brief summary

This study evaluates the efficacy of dexamethasone as a intracanal irrigant along with sodium hypochlorite 1% and 5.25% concentrations in post treatment pain for molar root canal retreatment.

Detailed description

Main objective of root canal retreatment is to alleviate pain and disinfect the rootcanal .However some patients may experience mild to severe pain following treatment , which leads to intake of painkillers orally for post operative pain management. So , this study evaluates the efficiency of dexamethasone used as intracanal irrigant in post treatment pain for molar root canal retreatment sodium hypochlorite (1% &5.25%) is used for disinfecting the canals patients will be grouped into Symptomatic and Asymptomatic patients requiring root canal retreatment and irrigants will be used in various combinations as mentioned below 1. 1% sodium hypochlorite alone 2.5ml in each canal along with ultrasonic activation 2. 1% sodium hypochlorite and dexamethasone 4mg,2.5ml in each canal along with ultrasonic activation 3. 5.25% sodium hypochlorite alone 2.5ml in each canal along with ultrasonic activation 4. 5.25% sodium hypochlorite and dexamethasone 4mg, 2.5ml in each canal along with ultrasonic activation calcium hydroxide is commonly used as intracanal medicament in all the patients post operative symptoms is evaluated at 12 hrs , 24 hrs,48 hrs, 72 hrs and 1 week followed by obturation is completed

Interventions

DRUGSodium Hypochlorite

Sodium hypochlorite is used as intracanal irrigant to minimize the post operative pain

Sponsors

Tamil Nadu Dr.M.G.R.Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
15 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* teeth previously treated or attempted root canal treatment, * teeth with or without symptoms, * periapical radiograph showing evidence of inadequate previous root canal treatment or periapical changes, * only teeth or at least one canal where complete removal of root canal filling material was possible and reach the working length in first appointment.

Exclusion criteria

* patient not willing for follow up, * teeth with extensive cervical or apical resorption that restricted the use of sodium hypochlorite irrigation, * teeth with poor periodontal status, teeth not suitable for post endodontic restoration, * patients with acute periapical abscess, * patients with systemic conditions preventing radiograph exposure or multi visit treatment, * pregnant patients, * patients with allergy to any known dental materials.

Design outcomes

Primary

MeasureTime frameDescription
post operative pain evaluation using various combination of irrigants: VAS scoreAt 6 hourspain scale is evaluated using VISUAL ANALOG SCALE (VAS) score (1-10) 1 is minimum amount of pain experienced and 10 is maximum amount of pain experienced \[1-3\] mild pain , \[4-7\] moderate pain , \[8-10\] severe pain .

Secondary

MeasureTime frameDescription
assessment of other variables in pain scalethrough study completion, an average of 1 weekcomparing the pain scale experienced between male and female in VAS score

Countries

India

Contacts

Primary ContactValliappan C.T, post graduate (MDS)
vrvalliappan2@gmail.com8870558925
Backup ContactAnand Sherwood, MDS, Ph.D
anand.sherwood@gmail.com9791443950

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026